A Single-Institution Experience with the AneuRx Stent Graft for Endovascular Repair of Abdominal Aortic Aneurysm

• Published in: Annals of vascular surgery Vol. 22; no. 2; pp. 221 - 226
• Main Authors: Smith, Sumona, Mountcastle, Sally, Burridge, Andrea, Dodson, Thomas F, Salam, Atef A, Kasirajan, Karthik, Milner, Ross, Veeraswamy, Ravi, Chaikof, Elliot L
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 01-03-2008
• Subjects: Aged; Aortic Aneurysm, Abdominal - mortality; Aortic Aneurysm, Abdominal - surgery; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation - adverse effects; Female; Humans; Intraoperative Complications; Male; Postoperative Complications; Stents - adverse effects; Surgery; Survival Rate
• ISSN: 0890-5096; 1615-5947
• DOI: 10.1016/j.avsg.2008.01.001

We report our experience of endovascular repair of infrarenal abdominal aortic aneurysms (EVAR) using the modular AneuRx Stent Graft System. We retrospectively reviewed the outcomes of 113 patients who underwent EVAR with the AneuRx system performed at our institution between October 1999 and August 2003. The mean age of this group was 72.5 years, with 71% ( n = 80) over the age of 70 years and 95% ( n = 107) males. Aneurysm diameter ranged 4.0-9.0 cm, with 33% ( n = 37) >6.0 cm. The average duration of late follow-up was 32.6 ± 24.8 months (median = 37). Successful deployment of the modular AneuRx system was noted in all patients. There were no immediate operative conversions, deaths within 24 hr of operation, or type I or III endoleaks observed at the completion of the procedure. Thirty-day mortality was 3.5% ( n = 4). Acute deployment-related complications occurred in 10% ( n = 13) of patients and included misdeployment, operative bleeding, arterial perforation/dissection, and access site complications. Acute systemic complications were present in nine patients, predominantly renal and cardiac complications. An endoleak noted at any time occurred in 25% of patients, with 40% of those requiring a secondary intervention. Two patients suffered late aneurysm rupture due to a type I endoleak and graft infection. Kaplan-Meier analysis revealed 5-year freedom from secondary intervention of 72.4%; freedom from aneurysm-related death of 93.9%; and probability of survival based on all-cause mortality of 60.1%. Endovascular treatment with the modular AneuRx Stent Graft System is safe and effective, producing acceptable rates of disease-free survival and mid-term clinical outcome.